Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

Sandostatin LAR®

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Sandostatin® SC

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Seebri Breezhaler®

glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Simbrinza®

brinzolamide, brimonidine tartrate
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada

Simulect®

basiliximab
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Finland Germany United Kingdom Austria Poland Netherlands Canada Turkey

Stalevo®

carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Austria Netherlands Canada Turkey Japan

Systane®

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Balance

propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Global Product Site

Systane® Ultra

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site